The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 136,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Covid-19 in pharma: synthetic COVID vaccines. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Covid-19 in pharma: synthetic COVID vaccines

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s Technology Foresights, which uses over 730,000 patents to analyze innovation intensity for the pharmaceutical industry, there are 80+ innovation areas that will shape the future of the industry.

Synthetic COVID vaccines is a key innovation area in Covid-19 therapy

Synthetic COVID vaccines refer to vaccines that are designed and produced using synthetic biology techniques, rather than traditional methods of vaccine production. A synthetic vaccine mainly consists of synthetic peptides, carbohydrates, or antigens for COVID. They are usually considered to be safer than vaccines from bacterial cultures. Creating vaccines synthetically can increase the speed of production.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 960+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of synthetic COVID vaccines.

Key players in synthetic COVID vaccines – a disruptive innovation in the pharmaceutical industry

 Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.   

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.  

Patent volumes related to synthetic COVID vaccines

Company Total patents (2021 - 2023) Premium intelligence on the world's largest companies
Johnson & Johnson 568 Unlock Company Profile
GSK 529 Unlock Company Profile
Sanofi 317 Unlock Company Profile
Mitsubishi Chemical Group 296 Unlock Company Profile
C. H. Boehringer Sohn 288 Unlock Company Profile
AstraZeneca 229 Unlock Company Profile
Novavax 224 Unlock Company Profile
Merck 198 Unlock Company Profile
Centre National de la Recherche Scientifique 155 Unlock Company Profile
Vertex Pharmaceuticals 154 Unlock Company Profile
Pfizer 131 Unlock Company Profile
Takeda Pharmaceutical 119 Unlock Company Profile
Curevac 116 Unlock Company Profile
Bavarian Nordic 95 Unlock Company Profile
FluGen 95 Unlock Company Profile
Autoimmune Technologies 82 Unlock Company Profile
Inovio Pharmaceuticals 75 Unlock Company Profile
Novartis 72 Unlock Company Profile
Altimmune 72 Unlock Company Profile
US Department of Health and Human Services 71 Unlock Company Profile
FDS Pharma 66 Unlock Company Profile
Zoetis 65 Unlock Company Profile
Valneva 63 Unlock Company Profile
Moderna 58 Unlock Company Profile
SEEK Group 58 Unlock Company Profile
The Administrators of The Tulane Educational Fund 55 Unlock Company Profile
St. Jude Children’s Research Hospital 55 Unlock Company Profile
CSL 54 Unlock Company Profile
F. Hoffmann-La Roche 50 Unlock Company Profile
Oswaldo Cruz Foundation 50 Unlock Company Profile
Compagnie Merieux Alliance 47 Unlock Company Profile
Academia Sinica 45 Unlock Company Profile
VLP Therapeutics 44 Unlock Company Profile
European Molecular Biology Laboratory 43 Unlock Company Profile
Precigen 40 Unlock Company Profile
TheVax Genetics Vaccine 40 Unlock Company Profile
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 39 Unlock Company Profile
Fastilium Property Group 39 Unlock Company Profile
Bio-Rad Laboratories 38 Unlock Company Profile
Theraclone Sciences 38 Unlock Company Profile
EpiVax 37 Unlock Company Profile
Mayo Clinic 35 Unlock Company Profile
Gilead Sciences 35 Unlock Company Profile
The United States Of America 35 Unlock Company Profile
Xiamen Innovax Biotech 34 Unlock Company Profile
PerkinElmer 34 Unlock Company Profile
Solon Eiendom 34 Unlock Company Profile
Longhorn Vaccines and Diagnostics 32 Unlock Company Profile
Grifols 32 Unlock Company Profile
Abbott Laboratories 30 Unlock Company Profile

Source: GlobalData Patent Analytics

Johnson & Johnson (J&J) is one of the leading patent filers in synthetic COVID vaccines. J&J researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious such as Covid-19, cardiovascular, and metabolic diseases. Jcovden is an approved synthetic vaccine, which was developed by Johnson & Johnson. GSK and Sanofi are some of the other key patent filers in synthetic COVID vaccines.

In terms of application diversity, Revvity leads the pack, while Gilead Sciences and Bio-Rad Laboratories stood in the second and third positions, respectively.

By means of geographic reach, SEEK Group held the top position, followed by Autoimmune Technologies and TheVax Genetics Vaccine.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.